The Europe Feed Vitamin Market is estimated to grow at a CAGR of 1.52% to reach USD 3.24 billion by 2026 from USD 4.08 billion in 2021. The European market is very diverse, fast changing and predicted for very high growth.
Feed Vitamins are given to farm animals when their vitamins requirement is not fulfilled by dietary supplements. These are necessary for the animals as their deficiency can cause various diseases and growth can be hindered. Vitamins which are essential includes Vitamin A, required for milk production, growth and reproduction. Vitamin D, helps in consuming calcium and phosphorus. Vitamin B, essential for monogastric animals and young calves.Vitamin E, is essential for hatching of eggs.
Europe Feed Vitamin Market Drivers:
The level of Vitamins should be maintained in the body of livestock which makes it necessary to give feed vitamins to them. Hence, increasing the growth of the market. There is a huge disease outbreak among the livestock which increases health concern and awareness for well-being and drives the fees vitamin market. The only drawback is the expenses during processing and for raw materials.
Mainly the feed vitamin market is segmented into
Including swine, ruminants, poultry, aquatic animals and others They are either single functioned or multi functioned. On the basis of formulation, they are divided into liquid, dry and others (powder, pellet). Poultry is the largest and fastest growing segment due to increase in population and hence increase in the demand of meant and egg.
Key Players:
Major companies dominating the market are S.A.S, Aland BASF SE, CSPC Pharmaceutical Group Ltd., Zhejiand Medicine company Ltd., Pharmative LLC, North China pharmaceutical corporation, Archer Daniels Midland company, Evonik industries and DSM N.V.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Vitamin Type
5.1.1 Vitamin A
5.1.2 Vitamin B
5.1.3 Vitamin C
5.1.4 Vitamin D
5.1.5 Vitamin E
5.1.6 Vitamin K
5.2 By Livestock Type
5.2.1 Swine
5.2.2 Ruminants
5.2.3 Poultry
5.2.4 Aquatic Animals
5.2.5 Others
5.3 By Formulation
5.3.1 Liquid
5.3.2 Dry
5.3.3 Others (Powder, Pellet)
5.4 By Function
5.4.1 Single Functioned
5.4.2 Multi Functioned
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 S.A.S
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Aland BASF SE
8.3 CSPC Pharmaceutical Group Ltd.
8.4 Zhejiand Medicine Company Ltd.
8.5 Pharmative LLC
8.6 North China pharmaceutical Corporation
8.7 Archer Daniels Midland Company
8.8 Evonik industries
8.9 DSM N.V.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
